COM:BEXIMCOPHARMA
Beximco Pharma
- Stock
Last Close
32.50
21/11 15:56
Market Cap
1.73M
Beta: -
Volume Today
15.96K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 2.84B - | 2.95B 3.84% | 3.21B 8.98% | 3.74B 16.45% | 4.91B 31.41% | 6.19B 25.91% | 6.69B 8.06% | 7.26B 8.63% | 9.46B 30.32% | 12.04B 27.20% | |
average payables | 426.63M - | 370.44M 13.17% | 398.36M 7.54% | 611.43M 53.48% | 887.78M 45.20% | 1.04B 17.35% | 1.28B 22.61% | 1.71B 34.18% | 2.22B 29.24% | 3.00B 35.36% | |
average receivables | 2.25B - | -3.31B 247.09% | -5.56B 67.98% | ||||||||
book value per share | 44.33 - | 46.89 5.79% | 50.39 7.45% | 56.20 11.54% | 60.71 8.01% | 66.32 9.25% | 72.87 9.87% | 83.01 13.91% | 91.01 9.64% | 97.89 7.56% | |
capex per share | -6.20 - | -6.36 2.56% | -5.76 9.37% | -7.01 21.64% | -11.34 61.84% | -10.19 10.15% | -5.10 49.92% | -5.73 12.40% | -6.59 14.90% | -6.07 7.83% | |
capex to depreciation | -40.12 - | -31.44 21.63% | -30.24 3.79% | -31.86 5.33% | -5.98 81.23% | -7.94 - | |||||
capex to operating cash flow | -2.78 - | -1.54 44.78% | -0.41 73.27% | -0.54 - | -0.45 16.77% | ||||||
capex to revenue | -0.26 - | -0.25 4.00% | -0.20 21.67% | -0.20 1.69% | -0.29 41.67% | -0.20 30.23% | -0.09 55.40% | -0.09 2.36% | -0.08 2.26% | -0.07 18.60% | |
cash per share | 8.12 - | 6.05 25.53% | 3.78 37.46% | 2.60 31.14% | 1.64 36.89% | 2.09 27.38% | 1.42 31.97% | 1.51 6.32% | 2.62 73.02% | 2.55 2.85% | |
days of inventory on hand | 183.75 - | 182.29 0.79% | 176.82 3.00% | 179.97 1.78% | 221.49 23.07% | 199.02 10.14% | 178.88 10.12% | 182.96 2.28% | 215.34 17.70% | 215.36 0.01% | |
days payables outstanding | 24.75 - | 21.39 13.54% | 23.01 7.53% | 34.37 49.40% | 38.38 11.67% | 32.67 14.87% | 38.94 19.16% | 46.07 18.31% | 47.72 3.59% | 58.72 23.05% | |
days sales outstanding | 55.71 - | -117.12 310.21% | |||||||||
debt to assets | 0.17 - | 0.16 4.54% | 0.16 4.23% | 0.13 13.55% | 0.26 89.87% | 0.27 7.13% | 0.21 23.51% | 0.15 30.31% | 0.19 28.04% | 0.15 17.95% | |
debt to equity | 0.24 - | 0.23 4.74% | 0.21 5.23% | 0.18 14.33% | 0.41 125.57% | 0.46 10.33% | 0.32 29.07% | 0.21 36.25% | 0.30 47.85% | 0.24 20.27% | |
dividend yield | 0.00 - | 0.04 554,913.75% | 0.03 26.78% | 0.01 75.80% | 0.02 192.43% | 0.03 38.93% | 0.04 29.93% | 0.01 67.56% | 0.05 255.46% | 0.07 57.38% | |
earnings yield | 0.23 - | 0.19 18.11% | 0.17 10.71% | 0.09 47.49% | 0.11 27.98% | 0.19 65.29% | 0.24 26.38% | 0.12 50.74% | 0.15 26.55% | 0.22 46.72% | |
enterprise value | 10.19B - | 12.61B 23.70% | 16.27B 29.07% | 29.52B 81.40% | 33.22B 12.56% | 29.10B 12.40% | 24.75B 14.97% | 51.02B 106.15% | 45.99B 9.85% | 30.83B 32.96% | |
enterprise value over ebitda | 3.73 - | 4.45 19.17% | 5.34 20.08% | 8.56 60.23% | 8.52 0.51% | 5.85 31.31% | 4.37 25.34% | 7.05 61.45% | 5.98 15.16% | 4.19 29.92% | |
ev to operating cash flow | 18.26 - | 9.83 46.16% | 4.46 54.59% | 8.37 - | 5.07 39.48% | ||||||
ev to sales | 0.97 - | 1.12 15.79% | 1.25 11.57% | 1.90 51.65% | 1.88 1.47% | 1.28 31.98% | 0.97 24.25% | 1.73 79.02% | 1.33 23.31% | 0.79 40.81% | |
free cash flow per share | -6.20 - | -6.36 2.56% | -5.76 9.37% | -7.01 21.64% | -7.26 3.64% | -3.55 51.06% | 7.33 306.20% | -5.73 178.27% | 5.72 199.82% | 7.56 32.11% | |
free cash flow yield | -0.45 - | -0.35 22.81% | -0.22 36.72% | -0.12 43.94% | -0.14 16.44% | -0.10 32.36% | 0.22 324.82% | -0.06 126.44% | 0.07 226.43% | 0.16 115.28% | |
graham net net | -5.94 - | -8.65 45.60% | -11.17 29.12% | -13.00 16.36% | -28.68 120.64% | -33.83 17.97% | -29.88 11.66% | -15.53 48.04% | -51.84 233.83% | -31.21 39.80% | |
graham number | 56.04 - | 60.12 7.28% | 70.47 17.22% | 79.45 12.73% | 88.13 10.93% | 100.73 14.30% | 113.68 12.85% | 146.52 28.89% | 153.35 4.66% | 150.91 1.59% | |
income quality | 0.72 - | 1.07 - | |||||||||
intangibles to total assets | 0.01 - | 0.01 12.40% | 0.01 7.91% | 0.01 55.20% | 0.04 207.58% | 0.04 8.49% | 0.04 4.90% | 0.04 1.46% | 0.08 114.63% | 0.08 1.46% | |
interest coverage | 3.65 - | 3.34 8.56% | 4.02 20.46% | 6.19 53.93% | 7.45 20.37% | 4.92 33.98% | 5.53 12.47% | 7.75 39.98% | 6.89 11.06% | 5.61 18.52% | |
interest debt per share | 11.92 - | 12.20 2.33% | 12.36 1.31% | 11.54 6.63% | 26.29 127.79% | 32.54 23.76% | 25.83 20.61% | 19.03 26.32% | 29.98 57.51% | 26.66 11.05% | |
inventory turnover | 1.99 - | 2.00 0.80% | 2.06 3.09% | 2.03 1.75% | 1.65 18.75% | 1.83 11.29% | 2.04 11.26% | 1.99 2.23% | 1.69 15.04% | 1.69 0.01% | |
invested capital | 0.24 - | 0.23 4.74% | 0.21 5.23% | 0.18 14.33% | 0.41 125.57% | 0.46 10.33% | 0.32 29.07% | 0.21 36.25% | 0.30 47.85% | 0.24 20.27% | |
market cap | 6.10B - | 8.11B 32.86% | 11.61B 43.21% | 25.20B 116.98% | 22.43B 10.99% | 16.23B 27.65% | 14.88B 8.32% | 44.06B 196.15% | 34.79B 21.05% | 21.35B 38.62% | |
net current asset value | 1.21B - | 285.94M 76.33% | 35.17M 87.70% | 119.11M 238.67% | -5.04B 4,333.80% | -6.09B 20.68% | -4.27B 29.80% | -1.11B 74.01% | -3.09B 178.53% | -661.26M 78.62% | |
net debt to ebitda | 1.50 - | 1.59 6.00% | 1.53 3.63% | 1.25 18.14% | 2.77 121.01% | 2.59 6.47% | 1.74 32.69% | 0.96 44.80% | 1.46 51.57% | 1.29 11.56% | |
net income per share | 3.15 - | 3.43 8.79% | 4.38 27.87% | 4.99 13.94% | 5.69 13.92% | 6.80 19.59% | 7.88 15.92% | 11.49 45.83% | 11.48 0.09% | 10.34 9.96% | |
operating cash flow per share | 4.08 - | 6.63 62.71% | 12.43 87.33% | 12.31 - | 13.64 10.74% | ||||||
payables turnover | 14.75 - | 17.06 15.66% | 15.87 7.00% | 10.62 33.07% | 9.51 10.45% | 11.17 17.47% | 9.37 16.08% | 7.92 15.48% | 7.65 3.47% | 6.22 18.73% | |
receivables turnover | 6.55 - | -3.12 147.57% | |||||||||
research and ddevelopement to revenue | 0.00 - | 0.00 4.27% | 0.00 0.78% | 0.00 0.15% | 0.00 0.62% | 0.00 21.75% | 0.01 225.90% | 0.01 12.63% | 0.01 1.94% | ||
return on tangible assets | 0.05 - | 0.05 3.15% | 0.06 20.34% | 0.07 3.58% | 0.06 8.62% | 0.06 5.89% | 0.07 13.55% | 0.10 40.03% | 0.08 17.46% | 0.07 13.96% | |
revenue per share | 23.52 - | 25.12 6.83% | 29.06 15.69% | 34.76 19.62% | 39.71 14.24% | 51.15 28.79% | 57.44 12.30% | 66.11 15.11% | 77.71 17.55% | 88.00 13.23% | |
roe | 0.07 - | 0.07 2.84% | 0.09 19.01% | 0.09 2.15% | 0.09 5.46% | 0.10 9.46% | 0.11 5.50% | 0.14 28.02% | 0.13 8.87% | 0.11 16.29% | |
roic | 0.06 - | 0.07 6.52% | 0.09 29.99% | 0.09 1.24% | 0.08 11.52% | 0.09 14.66% | 0.10 9.89% | 0.12 21.34% | 0.10 19.57% | 0.10 2.93% | |
sales general and administrative to revenue | 0.04 - | 0.04 0.61% | 0.03 2.81% | 0.03 2.59% | 0.03 3.67% | 0.03 5.50% | 0.03 6.18% | 0.03 1.80% | 0.03 10.38% | 0.03 10.44% | |
shareholders equity per share | 44.33 - | 46.89 5.79% | 50.39 7.45% | 56.20 11.54% | 60.71 8.01% | 66.32 9.25% | 72.87 9.87% | 83.01 13.91% | 91.01 9.64% | 97.89 7.56% | |
stock based compensation to revenue | |||||||||||
tangible asset value | 19.58B - | 20.68B 5.66% | 22.21B 7.37% | 24.61B 10.81% | 25.52B 3.72% | 27.98B 9.63% | 30.98B 10.69% | 35.44B 14.41% | 39.40B 11.18% | 42.22B 7.17% | |
tangible book value per share | 43.88 - | 46.37 5.66% | 49.78 7.37% | 55.16 10.81% | 57.22 3.72% | 62.73 9.63% | 69.46 10.74% | 79.44 14.36% | 88.32 11.18% | 94.62 7.14% | |
working capital | 4.52B - | 3.66B 19.07% | 3.53B 3.51% | 5.72B 62.17% | 2.33B 59.37% | 518.33M 77.72% | 1.69B 226.26% | 4.42B 161.44% | 5.68B 28.55% | 7.61B 33.92% |
All numbers in (except ratios and percentages)